Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Does Pfizer's Xeljanz share its CV safety questions with burgeoning JAK class?
Fierce Pharma
Sat, 02/23/19 - 04:32 pm
Pfizer
Xeljanz
JAK inhibitors
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
Stat
Thu, 02/21/19 - 12:41 pm
drug pricing
US Congress
Donald Trump
Richard Gonzalez
AbbVie
Ken Frazier
Merck
JNJ
Jennifer Taubert
Olivier Brandicourt
Sanofi
Pascal Soriot
AstraZeneca
Giovanni Caforio
Bristol-Myers Squibb
Albert Bourla
Pfizer
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Fierce Biotech
Wed, 02/20/19 - 06:09 pm
Cerevel Therapeutics
Pfizer
Otsuka
CMOs
Parkinson's Disease
epilepsy
Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report
Fierce Pharma
Wed, 02/20/19 - 11:59 am
M&A
oncology
neurology
Rare Diseases
Pfizer
Merck
JNJ
Biogen
Biomarin
Pfizer drops higher dose treatment arm in Xeljanz post-marketing study due to safety issues
CP Wire
Wed, 02/20/19 - 11:52 am
Pfizer
Xeljanz
post-marketing studies
FDA
rheumatoid arthritis
ulcerative colitis
Pfizer drops higher dose treatment arm in Xeljanz post-marketing study due to safety issues
Wed, 02/20/19 - 11:51 am
Pfizer
Xeljanz
post-marketing studies
FDA
rheumatoid arthritis
ulcerative colitis
Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster
Motley Fool
Tue, 02/19/19 - 12:20 pm
Pfizer
Inlyta
kidney cancer
Merck
Keytruda
Higher dose of Pfizer-Lilly drug helps reduce back pain in study
Yahoo/Reuters
Tue, 02/19/19 - 09:54 am
Pfizer
Eli Lilly
chronic low back pain
low back pain
clinical trials
tanezumab
opioid alternatives
Layoffs Hit California Biopharma Companies
BioSpace
Mon, 02/18/19 - 11:49 am
layoffs
Roche
Genentech
Pfizer
Aduro BioTech
Theravance
Merck
Merck, Pfizer drug combo extends kidney cancer survival -study
Yahoo/Reuters
Sun, 02/17/19 - 11:57 pm
Merck
Pfizer
kidney cancer
Keytruda
Inlyta
Sutent
Bayer stresses drug's tolerability in bid for prostate cancer market
Yahoo/Reuters
Fri, 02/15/19 - 10:25 am
Bayer
prostate cancer
darolutamide
Pfizer
JNJ
Pfizer still holds the lead in the erectile dysfunction market even as Viagra sales falter
CNBC
Thu, 02/14/19 - 09:48 am
Pfizer
Viagra
erectile dysfunction
Pfizer, Astellas chase new Xtandi nod with big survival numbers in prostate cancer
Fierce Pharma
Tue, 02/12/19 - 12:01 pm
Xtandi
Astellas
Pfizer
hormone-sensitive prostate cancer
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Sun, 02/10/19 - 11:08 pm
Motif Biosciences
Iclaprim
Merck
Keytruda
melanoma
JNJ
esketamine
ASCO
Pfizer
Veru. earnings
Aveo Pharmaceuticals
Calithera Biosciences
This Gene Therapy Stock Could Soon Hit The Auction Block — Here's Why
Investors Business Daily
Sun, 02/10/19 - 01:48 pm
uniQure
M&A
hemophilia B
AMT-061
Pfizer
Spark Therapeutics
Uniqure turns the screw on Spark and Pfizer
EP Vantage
Fri, 02/8/19 - 11:37 am
uniQure
Spark Therapeutics
Pfizer
AMT-061
hemophilia B
CEOs of Pfizer, Merck, Sanofi to testify in Senate drug pricing hearing
Biopharma Dive
Wed, 02/6/19 - 01:27 pm
Pfizer
Sanofi
Merck
drug pricing
Senate
Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.
Yahoo/Bloomberg
Wed, 02/6/19 - 09:51 am
BioNTech
IPOs
Pfizer
Sanofi
vaccines
cancer vaccines
Powerful Senate committee invites pharma executives to testify
Reuters
Tue, 02/5/19 - 11:31 pm
Senate
drug pricing
AbbVie
AstraZeneca
Bristol-Myers Squibb
JNJ
Merck
Pfizer
Sanofi
Moderna’s Not the Only One: A Look at the mRNA Market
BioSpace
Mon, 02/4/19 - 09:55 am
MRNA
Moderna Therapeutics
Pfizer
BioNTech
CureVac
Translate Bio
Pages
« first
‹ previous
…
87
88
89
90
91
92
93
94
95
…
next ›
last »